EUVIMEDEUVIMED entdecken
Crossref

A Practical In Silico Method for Predicting Compound Brain Concentration–Time Profiles: Combination of PK Modeling and Machine Learning

Koichi Handa iD, Daichi Fujita, Mariko Hirano, Saki Yoshimura, Michiharu Kageyama, Takeshi Iijima

Molecular Pharmaceutics · 2024

DOI: 10.1021/acs.molpharmaceut.4c00584 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2024. Verfasst von Koichi Handa und 5 weiteren Autor:innen. Beteiligte Einrichtung: Toxicology & DMPK Research Department, Teijin Institute for Bio-medical Research, Teijin Pharma Limited, 4-3-2 Asahigaoka, Hino-shi, Tokyo 191-8512, …. Hauptthemen laut MEDLINE: Machine Learning, Brain, Computer Simulation, Blood-Brain Barrier. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Given the aging populations in advanced countries globally, many pharmaceutical companies have focused on developing central nervous system (CNS) drugs. However, due to the blood-brain barrier, drugs do not easily reach the target area in the brain. Although conventional screening methods for drug discovery involve the measurement of (unbound fraction of drug) brain-to-plasma partition coefficients, it is difficult to consider nonequilibrium between plasma and brain compound concentration-time profiles. To truly understand the pharmacokinetics/pharmacodynamics of CNS drugs, compound concentration-time profiles in the brain are necessary; however, such analyses are costly and time-consuming and require a significant number of animals. Therefore, in this study, we attempted to develop an in silico prediction method that does not require a large amount of experimental data by combining modeling and simulation (M&S) with machine learning (ML). First, we constructed a hybrid model linking plasma concentration-time profile to the brain compartment that takes into account the transit time and brain distribution of each compound. Using mouse plasma and brain time experimental values for 103 compounds, we determined the brain kinetic parameters of the hybrid model for each compound; this case was defined as scenario I (a positive control experiment) and included the full brain concentration-time profile data. Next, we built an ML model using chemical structure descriptors as explanatory variables and rate parameters as the target variable, and we then input the predicted values from 5-fold cross-validation (CV) into the hybrid model; this case was defined as scenario II, in which no brain compound concentration-time profile data exist. Finally, for scenario III, assuming that the brain concentration is obtained at only one time point, we used the brain kinetic parameters from the result of the 5-fold CV in scenario II as the initial values for the hybrid model and performed parameter refitting against the observed brain concentration at that time point. As a result, the RMSE/R2-values of the brain compound concentration-time profiles over time were 0.445/0.517 in scenario II and 0.246/0.805 in scenario III, indicating the method provides high accuracy and suggesting that it is a practical method for predicting brain compound concentration-time profiles.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Machine LearningBrainComputer SimulationBlood-Brain BarrierAnimalsMiceModels, BiologicalCentral Nervous System AgentsTissue DistributionDrug Discovery

Stichwörter der Autor:innen

CNSPK parametersQSARcompound brain concentration−time profilescompound designmachine learningmodeling and simulationmouse pharmacokineticsrandom forest

Substanzen

Central Nervous System Agents

Autor:innen und Institutionen

  • Toxicology & DMPK Research Department, Teijin Institute for Bio-medical Research, Teijin Pharma Limited, 4-3-2 Asahigaoka, Hino-shi, Tokyo 191-8512, Japan.

ORCID-Profile: Koichi Handa

Zitieren

APA

Handa, K., Fujita, D., Hirano, M., Yoshimura, S., Kageyama, M., & Iijima, T. (2024). A Practical In Silico Method for Predicting Compound Brain Concentration–Time Profiles: Combination of PK Modeling and Machine Learning. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.4c00584

Vancouver

Handa K, Fujita D, Hirano M, Yoshimura S, Kageyama M, Iijima T. A Practical In Silico Method for Predicting Compound Brain Concentration–Time Profiles: Combination of PK Modeling and Machine Learning. Molecular Pharmaceutics. 2024. doi:10.1021/acs.molpharmaceut.4c00584

BibTeX
@article{Handa2024,
  author = {Handa, Koichi and Fujita, Daichi and Hirano, Mariko and Yoshimura, Saki and Kageyama, Michiharu and Iijima, Takeshi},
  title = {A Practical In Silico Method for Predicting Compound Brain Concentration–Time Profiles: Combination of PK Modeling and Machine Learning},
  journal = {Molecular Pharmaceutics},
  year = {2024},
  doi = {10.1021/acs.molpharmaceut.4c00584}
}
Kostenlos starten →